Nektaria Dimopoulos

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Ian D. Davis, Weisan Chen, Heather Jackson et al. · Proceedings of the National Academy of Sciences · 2004 · 437 citations · Full text

MEK Inhibition, Alone or in Combination with BRAF Inhibition, Affects Multiple Functions of Isolated Normal Human Lymphocytes and Dendritic Cells

Laura J. Vella, Anupama Pasam, Nektaria Dimopoulos et al. · Cancer Immunology Research · 2014 · 138 citations

Immune Regulation, Immunology, Immunologic Mechanism +20

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.

Mark Shackleton, Ian D. Davis, Wendie Hopkins et al. · PubMed · 2004 · 123 citations

Immunology, Immunoediting, Adjuvant Flt3 Ligand +18

Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

Theo Nicholaou, Lisa M. Ebert, Ian D. Davis et al. · Clinical Cancer Research · 2009 · 118 citations · Full text

Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4

Oliver Klein, Lisa M. Ebert, Theo Nicholaou et al. · Clinical Cancer Research · 2009 · 97 citations · Full text